Holen Sie sich die Stockscreener-App
1.085
5.34%
0.055
Schlusskurs vom Vortag:
$1.03
Offen:
$1.03
24-Stunden-Volumen:
1.85M
Relative Volume:
0.75
Marktkapitalisierung:
$423.55M
Einnahmen:
$86.26M
Nettoeinkommen (Verlust:
$-50.08M
KGV:
-4.4304
EPS:
-0.2449
Netto-Cashflow:
$-94.48M
1W Leistung:
+8.50%
1M Leistung:
+20.62%
6M Leistung:
-24.13%
1J Leistung:
+17.73%
1-Tages-Spanne:
$1.02
$1.09
1-Wochen-Bereich:
$0.9972
$1.09
52-Wochen-Spanne:
$0.8701
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
50 MILK STREET, BOSTON
Compare LAB vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.085 | 402.08M | 86.26M | -50.08M | -94.48M | -0.2449 |
ABT
Abbott Laboratories
|
86.61 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.15 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.83 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.77 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.75 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
STANDARD BIOTOOLS (LAB) CFO has 18,871 shares withheld for RSU taxes - Stock Titan
Standard Biotools (LAB) SVP has 25,729 shares withheld for taxes - Stock Titan
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax obligations - Stock Titan
Standard BioTools Q1 2026 Earnings: Massive EPS Beat Fails to Lift Shares Amid Revenue UncertaintyProfit Announcement - Newser
DKSH : and Standard BioTools Announce Distribution Partnership to Expand Spatial Biology and Proteomics Solutions in Australia and New Zealand - marketscreener.com
Standard BioTools (LAB) Q1 2026 Earnings: $0.33 EPS Surges Past $-0.06 EstimatesStock Idea Hub - Newser
Standard BioTools (LAB) Q1 2026 Earnings Surprise: EPS $0.33, Up SignificantCrowd Consensus Signals - Newser
SomaLogic stock (US82489T1043): merger with Standard BioTools reshapes proteomics player - AD HOC NEWS
SomaLogic Inc stock (US82489T1043): Illumina merger closes and reshapes proteomics story - AD HOC NEWS
MAK Capital (NASDAQ: LAB) reports 6.7% stake in Standard BioTools - Stock Titan
Viking Global (LAB) holds 58.65M shares (~15%) of Standard BioTools - Stock Titan
Should You Sell Standard BioTools (LAB) After -1.52% Drop? 2026-05-15Collaborative Trading Signals - Newser
Standard BioTools (LAB) Q1 2026 Earnings: Why the Beat MattersBinary Event - newser.com
SomaLogic stock (US82489T1043): Completed $350M sale to Illumina - AD HOC NEWS
MSN Money - MSN
Standard BioTools (LAB) reports Q1 loss, tops revenue estimates - MSN
Standard BioTools Inc. (LAB) Stock Analysis: A 55% Potential Upside Beckons Investors - DirectorsTalk Interviews
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price - TipRanks
Number of shareholders of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Standard BioTools (NASDAQ: LAB) posts Q1 2026 profit on SomaScan sale windfall - Stock Titan
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
LAB Financials: Income Statement, Balance Sheet & Cash Flow | STANDARD BIOTOOLS INC - Stock Titan
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools: Q1 Earnings Snapshot - marketscreener.com
Standard BioTools Highlights Improved Q1 2026 Results, Outlook - TipRanks
Standard BioTools 1Q Loss $14.6M >LAB - Moomoo
Standard BioTools 1Q Rev $21.1M >LAB - Moomoo
Standard BioTools ends quarter with $524M as loss shrinks 54% - Stock Titan
Standard BioTools (LAB) Q1 2026 results show big cash boost and EBITDA gains - Stock Titan
Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Standard BioTools Reports First Quarter 2026 Financial Results - ChartMill
LAB (Standard BioTools) posts strong Q4 2025 EPS beat, with shares registering mild gains in recent trading.EBITDA Analysis - Newser
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 - Investing News Network
Standard BioTools Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Standard Biotools Inc-Aktie (LAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kim Hanjoon Alex | Chief Financial Officer |
Apr 06 '26 |
Option Exercise |
0.00 |
70,183 |
0 |
2,800,702 |
| Casdin Partners Master Fund, L | Director |
Dec 04 '25 |
Buy |
1.45 |
150,000 |
217,020 |
72,100,000 |
| Casdin Partners Master Fund, L | Director |
Dec 02 '25 |
Buy |
1.42 |
125,000 |
177,512 |
71,875,000 |
| Casdin Partners Master Fund, L | Director |
Dec 03 '25 |
Buy |
1.44 |
75,000 |
108,037 |
71,950,000 |
| Casdin Partners Master Fund, L | Director |
Nov 25 '25 |
Buy |
1.30 |
7,550,000 |
9,838,405 |
71,750,000 |
| Casdin Partners Master Fund, L | Director |
Nov 24 '25 |
Buy |
1.43 |
150,000 |
214,875 |
64,200,000 |
| Casdin Partners Master Fund, L | Director |
Nov 20 '25 |
Buy |
1.30 |
450,000 |
586,260 |
64,050,000 |
| Casdin Partners Master Fund, L | Director |
Nov 19 '25 |
Buy |
1.28 |
350,000 |
448,910 |
63,600,000 |
| Casdin Partners Master Fund, L | Director |
Nov 18 '25 |
Buy |
1.23 |
275,000 |
339,405 |
63,250,000 |
| Casdin Partners Master Fund, L | Director |
Nov 13 '25 |
Buy |
1.20 |
450,000 |
541,395 |
62,500,000 |
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):